Results 1 to 10 of about 660 (160)

The Influence of Booster Shot and SARS-CoV-2 Infection on the Anti-Spike Antibody Concentration One Year after the First COVID-19 Vaccine Dose Administration [PDF]

open access: yesVaccines, 2023
This study pictures the humoral response of 100 vaccinees to Pfizer/BioNTech COVID-19 vaccine over a year, with particular focus on the influence of a booster shot administered around 10 months after the primary immunization.
Jakub Swadźba   +5 more
doaj   +2 more sources

Head-to-Head Comparison of 5 Anti-SARS-CoV-2 Assays Performance in One Hundred COVID-19 Vaccinees, over an 8-Month Course [PDF]

open access: yesDiagnostics, 2022
The immunoassays used to measure anti-spike SARS-CoV-2 antibodies are widely available on the market. However, their performance in COVID-19 vaccinees is not yet adequately assessed.
Jakub Swadźba   +5 more
doaj   +2 more sources

Three Years After COVID-19 Vaccination, Anti-Spike SARS-CoV-2 Antibody Concentration Decreases and Is Accompanied by Increasing Anti-Nucleocapsid Seropositivity [PDF]

open access: yesViruses
Background/Objectives: The anti-spike (S) SARS-CoV-2 antibodies confer neutralizing properties and their concentration may be related to COVID-19 protection.
Tomasz Anyszek   +3 more
doaj   +2 more sources

DiagSet: a dataset for prostate cancer histopathological image classification [PDF]

open access: yesScientific Reports
Cancer diseases constitute one of the most significant societal challenges. In this paper, we introduce a novel histopathological dataset for prostate cancer detection.
Michał Koziarski   +10 more
doaj   +2 more sources

High Concentration of Anti-SARS-CoV-2 Antibodies 2 Years after COVID-19 Vaccination Stems Not Only from Boosters but Also from Widespread, Often Unrecognized, Contact with the Virus [PDF]

open access: yesVaccines
This study follows 99 subjects vaccinated with Pfizer/BioNTech COVID-19 vaccines over two years, with particular focus on the last year of observation (between days 360 and 720).
Jakub Swadźba   +4 more
doaj   +2 more sources

A comparison of 7 commercial anti-SARS-CoV-2 antibody immunoassays [PDF]

open access: yesArchives of Medical Science, 2020
Introduction Serological testing in SARS-CoV-2 infection is gaining both patients’ and clinicians’ attention. Antibody assessment has potential multidirectional utility, hampered by the scarcity of clinical validation studies of the tests available on ...
Jakub Swadźba   +3 more
doaj   +2 more sources

IgE-based analysis of sensitization and cross-reactivity to yellow mealworm and edible insect allergens before their widespread dietary introduction [PDF]

open access: yesScientific Reports
The European Commission authorized the use of dried yellow mealworm (Tenebrio molitor - TM) as a food ingredient under Regulation EU 2021/882. As TM emerges as an important allergen source, sensitization and allergy to TM in various populations need ...
Emilia Majsiak   +7 more
doaj   +2 more sources

Correction: IgE-based analysis of sensitization and cross-reactivity to yellow mealworm and edible insect allergens before their widespread dietary introduction [PDF]

open access: yesScientific Reports
Emilia Majsiak   +7 more
doaj   +2 more sources

The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays

open access: yesPractical Laboratory Medicine, 2021
Objectives: This study was aimed at providing some insights into the real-life performance of the commercial, clinically validated anti-SARS-CoV-2 antibody assays.
Jakub Swadźba   +5 more
doaj   +1 more source

Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview

open access: yesAlzheimer's &Dementia, Volume 18, Issue 10, Page 1868-1879, October 2022., 2022
Abstract Introduction The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same biochemical profile, interpretation and reporting of results may differ, which can lead to misunderstandings and raises questions about the commutability of tests.
Constance Delaby   +71 more
wiley   +1 more source

Home - About - Disclaimer - Privacy